Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel on the BD FACSLyric™ Flow Cytometer

CompletedOBSERVATIONAL
Enrollment

371

Participants

Timeline

Start Date

April 26, 2021

Primary Completion Date

December 29, 2023

Study Completion Date

December 29, 2023

Conditions
Chronic Lymphoproliferative Diseases (CLPD)
Interventions
DIAGNOSTIC_TEST

IUO CLPD Limited Panel

This Investigational Panel , comprised of 2 reagents , is intended for in vitro diagnostic use for qualitative flow-cytometric immunophenotyping of mature lymphocyte populations. These reagents are used as an aid in the differential diagnosis of hematologically abnormal patients having Chronic Lymphoproliferative Disease .

Trial Locations (6)

5000

Kantonsspital Aarau, Aarau

27514

University of North Carolina, Chapel Hill

37007

University of Salamanca, Salamanca

78229

Corepath Laboratories, San Antonio

Unknown

Champalimaud Foundation, Lisbon

CB2 0QQ

Cambridge university hospital, Cambridge

Sponsors
All Listed Sponsors
lead

Becton, Dickinson and Company

INDUSTRY